Evaluation of a Cognitive Remediation Program for Mood Disorders (ECO-DBP)

  • End date
    Feb 18, 2023
  • participants needed
  • sponsor
    Centre hospitalier de Ville-Evrard, France
Updated on 4 March 2022


Psychotherapeutic management of cognitive disorders in patients suffering from a mood disorder

Condition Taking Charge of Cognitive Impairment in Patients With Mood Disorders
Treatment Evaluation
Clinical Study IdentifierNCT04354974
SponsorCentre hospitalier de Ville-Evrard, France
Last Modified on4 March 2022


Yes No Not Sure

Inclusion Criteria

Age between 18 and 65 years old
The patient's previous diagnosis of Bipolar-Related Disorder or Depressive Disorder according to the DSM-5 criteria
Mood stabilized with respect to depressive symptomatology (absence or presence of residual mild depressive symptoms (HDRS-17 18))
Mood stabilized with respect to manic symptomatology (absence or presence of residual mild manic symptoms (YMRS 8))
Stable and effective treatment at minimum dose for at least 2 months
Cognitive complaint expressed by the patient, and detected by the patient's referring psychiatrist
Free and Informed Consent Form read, initialled and signed
Patient affiliated to a social protection scheme or beneficiary of State Medical Aid
Patient knowing how to speak French -

Exclusion Criteria

Presence of a DSM-5 disorder, other than a mood, anxiety or personality disorder
Substance addiction or abuse (Alcohol, psychoactive substances) in the past 12 months
Manic, hypomanic or major depressive episode in the last 2 months
Somatic or neurological disorder which may lead to cognitive impairment
Current or less than one month's commitment to another research protocol
A neuropsychological assessment prior to 6 months
Patient under protective custody, guardianship or reinforced guardianship
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note